Navigate EU & Turkish Funding Synergies
An interactive companion to the Funding Synergies Manual v.01 (September 2026). Explore the funds, discover strategic pathways, and build combined-funding strategies for research, innovation and enterprise across the quadruple helix.
What a synergy is — and why you need one
No single funding instrument covers the full progression of an idea from early research to deployment and market access. Any organisation with a strategic ambition will need to combine instruments in a wider, longer-term strategy rather than chasing them one at a time. That combination is what we call a synergy: one programme creates a result, a capability, a partnership, or an exploitable asset which becomes the basis for pursuing another.
Every pathway in this portal is built from three operating modes:
One instrument prepares the ground for another. The pathway moves in stages.
Example: A national R&D project produces evidence that later strengthens a Horizon Europe proposal.
Different instruments run at the same time but pay for different activities, roles or cost categories.
Example: An SME receives capacity-building services while separate R&D grants fund product development.
A grant-funded project is combined with non-grant finance to support deployment, commercialisation or scale.
Example: A Horizon Europe result feeds into EIC, EIF, EIB, EBRD or national investment-backed growth finance.
The modes can overlap: a pathway may start sequentially, be pursued in parallel, and later become layered with investment finance. What matters is that work and cost allocation, timing, governance and outputs remain clear.
Eligible is not the same as ready
Three questions that must be kept apart.
Is the organisation legally allowed to apply under the programme and the specific call?
Does the call fit the organisation's objective, capacity, timing and role?
Does the organisation or consortium have a realistic chance of success in the evaluation?
Many applicants stop at eligibility, but this is only one factor. Eligibility means an organisation is welcome to apply. Suitability asks whether it is sensible to do so. Competitiveness asks whether the applicant can credibly get a positive evaluation. A Turkish organisation may be eligible for a European call but unsuitable as coordinator because it lacks partner depth, administrative capacity or evidence. In that case the right answer is not “do not apply”. It is “not yet — build the missing readiness first”.
Open the Ready-to-Combine Self-AssessmentFour compliance boundaries
The rules every combined pathway must respect.
The same cost, deliverable, staff time or equipment use must not be charged twice.
Each instrument keeps its own eligibility, contracting, reporting, procurement, state-aid and audit logic.
Every instrument in a pathway needs its own file, budget code, evidence base and financial record.
Thematic similarity between programmes does not mean they can be combined on the same activity or budget line.
These rules apply to all actors, but they matter most where national grants, EU grants, IPA instruments, procurement procedures, SME support and financial instruments appear in the same pathway.
Open the Risk Cards deckFour steps, start to submission.
Everything happens on this page or one click away. The menu is always one tap away, so you can move between steps without losing your place.
Pick your organisation type in the menu or in the Instrument Explorer. The funds, plays and tools are then filtered to what you can actually apply for.
Browse 77 funding instruments by layer and type. Open any card for the full manual description, eligibility, synergies, pitfalls and the official call page.
Answer three short questions in the Play Navigator to get one of seven strategic pathways, with a phased timeline linking to each instrument.
Use the 7 tools — self-assessment, concept note, cost matrix and more. Your entries stay in your browser and export to PDF.
Explore, navigate, build.
A layered workspace that mirrors how applicants move from discovery to design to submission.